After 4 years of living with inflammatory breast cancer, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, she still felt fine, which she attributed to her care choices, she explained during her speech at The American Journal of Managed Care's Patient-Centered Oncology Care meeting in Baltimore, Maryland.
After 4 years of living with inflammatory breast cancer, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, said she felt fine during her speech at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting in Baltimore, Maryland.
Although she has Stage IV breast cancer for a type of the disease where the survival rate to 5 years is under 20%, she works full time and continues to have a busy social life.
“And the reason why I am doing well, in part, is because the care is matching my goals and my values,” Ms Berman explained.
While some patients may choose aggressive, costly treatment to the end, she went a different route and decided against a mastectomy and aggressive treatments. Instead, her priority was quality of life. And evidence suggests that her decision will actually make her live longer, she said.
“I’m the walking Triple Aim,” Ms Berman said. “I have better health, I have better care, and I have significantly lower costs.”
In fact, she estimates that she has probably saved approximately $1 million over the past 4 years. The important thing is that her care team has supported her decision and understood what she wanted to get out of her life, Ms Berman explained.
Unfortunately, these are not decisions that most people ever discuss with their providers. Of the 2 oncologists she saw, one was in line with her plan for quality of life, while the other wanted to start the aggressive treatments that she felt would “drive me into the ground.”
Ms Berman called her choice of care the “Niagara Falls trajectory,” wherein she would experience a lot of good days and would get dropped off the cliff at the end. The path of aggressive treatments would do the opposite: drop her off the cliff at the beginning and float her out to the same endpoint.
She decided to forgo the aggressive treatments because she wanted to maximize the good days while minimizing the bad ones. And she has. Over the last 4 years, Ms Berman has jet skied out to Liberty Island and ridden camels in the Jordanian desert.
“The only thing we know in life is where we start and where we end,” she said. “This is the same for everybody. But I had values that said this is the trajectory I am trying to aim for.”
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Community Engagement, Culturally Tailored Care as a Gateway to Advancing Health Equity
October 16th 2024Many talks at the Association of Cancer Care Centers (ACCC) 41st National Oncology Conference advocated for the adoption of culturally relevant care, the leveraging of community partnerships, and community engagement to build better trust with patients and improve outcomes.
Read More
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More